MD

Manash Das

Active Director Director DIN 08596984
DIN 08596984 First appointment Oct 2019 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2019
Shareholding value •••• Premium profile

About Manash Das

Data last updated:

Manash Das is a Director at Biozeal Healthcare Private Limited (since 2019). The company operates in Chemicals. Biozeal Healthcare Private Limited reported revenue of ₹3.28 Cr (FY 2025).

DIN 08596984
Primary Designation Director
Industry Chemicals
First Appointment 25 Oct 2019
Oldest Company Age 7 yrs
Largest company Biozeal Healthcare Private Limited · ₹3.28 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Biozeal Healthcare Private Limited U24230PN2019PTC187498
Director25 Oct 20192019₹3.28 Cr (FY 2025)Active

Board colleagues of Manash Das

NameDINCompanyDesignation
Bhaskar Das08596985Biozeal Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Biozeal Healthcare Private Limited
Premium access

Shareholding and investment profile for Manash Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manash Das

Manash Das currently holds 1 directorship: Biozeal Healthcare Private Limited (Director, since 25 Oct 2019, revenue ₹3.28 Cr (FY 2025)).

Manash Das was first appointed on 25 Oct 2019 as Director at Biozeal Healthcare Private Limited.

The current boards of Manash Das's companies include Bhaskar Das (Biozeal Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available